S1PR1 and infection: On the other hand, the egress from lymph nodes of memory and effector cells involved in antimicrobial responses appears to be unaffected by the S1PR1 antagonism, therefore this mechanism does not explain the increased risk of infections and potential reduction in vaccine efficacy observed with fingolimod [49–55].